{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:00:58Z","timestamp":1746849658628,"version":"3.40.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Xinjiang Natural Science Foundation General Project","award":["No. 2022D01C630"],"award-info":[{"award-number":["No. 2022D01C630"]}]},{"name":"National Natural Science Foundation of China Regional Project","award":["No. 82360520"],"award-info":[{"award-number":["No. 82360520"]}]},{"name":"Xinjiang Natural Science Foundation for Distinguished Young Scholars","award":["No. 2022D01E84"],"award-info":[{"award-number":["No. 2022D01E84"]}]},{"name":"Xinjiang Tianshan Talent Training Program","award":["No. 2023TSYCCX0061"],"award-info":[{"award-number":["No. 2023TSYCCX0061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Epigenetics & Chromatin"],"DOI":"10.1186\/s13072-025-00592-8","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T03:23:55Z","timestamp":1746761035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNMT3B promotes the progression of pheochromocytoma by mediating the hypermethylation of LRP1B promoter"],"prefix":"10.1186","volume":"18","author":[{"given":"Min","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanrong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"592_CR1","doi-asserted-by":"publisher","unstructured":"Calsina B, Pi\u00f1eiro-Y\u00e1\u00f1ez E, Mart\u00ednez-Montes AM, Caleiras E, Fern\u00e1ndez-Sanrom\u00e1n A, Monteagudo M, Torres-P\u00e9rez R, Fustero-Torre C, Pulgar\u00edn-Alfaro M, Gil E et al. Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma. Nat Commun. 2023;14(1). https:\/\/doi.org\/10.1038\/s41467-023-36769-6. PMID: WOS:000955827800007. ARTN 1122.","DOI":"10.1038\/s41467-023-36769-6"},{"issue":"8","key":"592_CR2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2967\/jnumed.120.259689","volume":"62","author":"JA Carrasquillo","year":"2021","unstructured":"Carrasquillo JA, Chen CC, Jha A, Ling A, Lin FI, Pryma DA, Pacak K. Imaging of pheochromocytoma and paraganglioma. J Nucl Med. 2021;62(8):1033\u201342. https:\/\/doi.org\/10.2967\/jnumed.120.259689. PMID: WOS:000711570000009.","journal-title":"J Nucl Med"},{"key":"592_CR3","doi-asserted-by":"publisher","unstructured":"Martinelli S, Amore F, Canu L, Maggi M, Rapizzi E. Tumour microenvironment in pheochromocytoma and paraganglioma. Front Endocrinol. 2023;14. https:\/\/doi.org\/10.3389\/fendo.2023.1137456. PMID: WOS:000963005200001. ARTN 1137456.","DOI":"10.3389\/fendo.2023.1137456"},{"issue":"3","key":"592_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1590\/S1677-5538.Ibju.2023.0038","volume":"49","author":"JV Lima","year":"2023","unstructured":"Lima JV, Kater CE. The pheochromocytoma\/paraganglioma syndrome: an overview on mechanisms, diagnosis and management. Int Braz J Urol. 2023;49(3):307\u201319. https:\/\/doi.org\/10.1590\/S1677-5538.Ibju.2023.0038. PMID: WOS:001021771100004.","journal-title":"Int Braz J Urol"},{"issue":"7","key":"592_CR5","first-page":"2886","volume":"13","author":"C Ye","year":"2023","unstructured":"Ye C, Chong W, Liu Y, Zhu X, Ren H, Xu K, Xie X, Du F, Zhang Z, Wang M, et al. Suppression of tumorigenesis in LUAD by LRP1B through regulation of the IL-6-JAK-STAT3 pathway. Am J Cancer Res. 2023;13(7):2886\u2013905. PMID: 37560001.","journal-title":"Am J Cancer Res"},{"key":"592_CR6","doi-asserted-by":"publisher","unstructured":"Brown LC, Tucker MD, Sedhom R, Schwartz EB, Zhu J, Kao C, Labriola MK, Gupta RT, Marin D, Wu Y, et al. LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types. J Immunother Cancer. 2021;9(3). https:\/\/doi.org\/10.1136\/jitc-2020-001792. PMID: 33653800.","DOI":"10.1136\/jitc-2020-001792"},{"issue":"1","key":"592_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2017.04.010","volume":"357","author":"Z Wang","year":"2017","unstructured":"Wang Z, Sun P, Gao C, Chen J, Li J, Chen Z, Xu M, Shao J, Zhang Y, Xie J. Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells. Exp Cell Res. 2017;357(1):1\u20138. https:\/\/doi.org\/10.1016\/j.yexcr.2017.04.010. PMID: 28408316.","journal-title":"Exp Cell Res"},{"issue":"2","key":"592_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00109-018-01732-2","volume":"97","author":"Y Asano","year":"2019","unstructured":"Asano Y, Takeuchi T, Okubo H, Saigo C, Kito Y, Iwata Y, Futamura M, Yoshida K. Nuclear localization of LDL receptor-related protein 1B in mammary gland carcinogenesis. J Mol Med (Berl). 2019;97(2):257\u201368. https:\/\/doi.org\/10.1007\/s00109-018-01732-2. PMID: 30607440","journal-title":"J Mol Med (Berl)"},{"key":"592_CR9","doi-asserted-by":"publisher","unstructured":"Pr\u00edncipe C, de Sousa IJD, Prazeres H, Soares P, Lima RT. LRP1B: A giant lost in Cancer translation. Pharmaceuticals-Base. 2021;14(9). https:\/\/doi.org\/10.3390\/ph14090836. PMID: WOS:000701275400001 ARTN 836.","DOI":"10.3390\/ph14090836"},{"issue":"6","key":"592_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00259-017-3919-6","volume":"45","author":"Y Ohshima","year":"2018","unstructured":"Ohshima Y, Sudo H, Watanabe S, Nagatsu K, Tsuji AB, Sakashita T, Ito YM, Yoshinaga K, Higashi T, Ishioka NS. Antitumor effects of radionuclide treatment using alpha-emitting meta-(211)At-astato-benzylguanidine in a PC12 pheochromocytoma model. Eur J Nucl Med Mol Imaging. 2018;45(6):999\u20131010. https:\/\/doi.org\/10.1007\/s00259-017-3919-6. PMID: 29350258","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"592_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/carcin\/bgz199","volume":"41","author":"JS Li","year":"2020","unstructured":"Li JS, Su XL, Dai L, Chen N, Fang C, Dong ZX, Fu JM, Yu Y, Wang WS, Zhang HT, et al. Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer. Carcinogenesis. 2020;41(2):235\u201344. https:\/\/doi.org\/10.1093\/carcin\/bgz199. PMID: WOS:000537366000012.","journal-title":"Carcinogenesis"},{"issue":"2","key":"592_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2214\/AJR.12.9126","volume":"200","author":"K Leung","year":"2013","unstructured":"Leung K, Stamm M, Raja A, Low G, Pheochromocytoma. The range of appearances on ultrasound, CT, MRI, and functional imaging. Am J Roentgenol. 2013;200(2):370\u20138. https:\/\/doi.org\/10.2214\/Ajr.12.9126 PMID: WOS:000313957400037.","journal-title":"Am J Roentgenol"},{"issue":"1","key":"592_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.7150\/thno.77918","volume":"13","author":"M Ullrich","year":"2023","unstructured":"Ullrich M, Richter S, Liers J, Drukewitz S, Friedemann M, Kotzerke J, Ziegler CG, N\u00f6lting S, Kopka K, Pietzsch J. Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models. Theranostics. 2023;13(1):278\u201394. https:\/\/doi.org\/10.7150\/thno.77918. PMID: WOS:000894576600003.","journal-title":"Theranostics"},{"key":"592_CR14","doi-asserted-by":"publisher","unstructured":"Rui Wang GZ, Zhu X, Xu Y, Cao N, Li Z, Han C, Shen MQY, Dong J, Zhao FMA. Prognostic Implications of LRP1B and Its Relationship with the Tumor-Infiltrating Immune Cells in Gastric Cancer. Cancers. 2023;15(24):5759. https:\/\/doi.org\/10.3390\/cancers15245759","DOI":"10.3390\/cancers15245759"},{"key":"592_CR15","doi-asserted-by":"publisher","unstructured":"Hao F, Ma Q, Zhong DS. Potential predictive value of comutant LRP1B and FAT for immune response in non-small cell lung cancer LRP1B and FAT comutation enhance immune response. Transl Oncol. 2022;24.https:\/\/doi.org\/10.1016\/j.tranon.2022.101493 PMID: WOS:000835517900004. ARTN 101493.","DOI":"10.1016\/j.tranon.2022.101493"},{"issue":"6","key":"592_CR16","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000517372","volume":"88","author":"IDJ de Sousa","year":"2021","unstructured":"de Sousa IDJ, Cunha AI, Saraiva IA, Portugal RV, Gimba ERP, Guimaraes M, Prazeres H, Lopes JM, Soares P, Lima RT. LRP1B expression as a putative predictor of response to pegylated liposomal doxorubicin treatment in ovarian Cancer. Pathobiology. 2021;88(6):400\u201311.https:\/\/doi.org\/10.1159\/000517372 PMID: WOS:000713908500001.","journal-title":"Pathobiology"},{"issue":"1","key":"592_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/onc.2016.143","volume":"36","author":"H Prazeres","year":"2017","unstructured":"Prazeres H, Torres J, Rodrigues F, Pinto M, Pastoriza MC, Gomes D, Cameselle-Teijeiro J, Vidal A, Martins TC, Sobrinho-Simoes M, et al. Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells (30, Pg 1302, 2010). Oncogene. 2017;36(1):146. https:\/\/doi.org\/10.1038\/onc.2016.143. PMID: WOS:000394069100013.","journal-title":"Oncogene"},{"issue":"7","key":"592_CR18","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/en.2014-1027","volume":"155","author":"S Nolting","year":"2014","unstructured":"Nolting S, Giubellino A, Tayem Y, Young K, Lauseker M, Bullova P, Schovanek J, Anver M, Fliedner S, Korbonits M, et al. Combination of 13-Cis retinoic acid and Lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice. Endocrinology. 2014;155(7):2377\u201390. https:\/\/doi.org\/10.1210\/en.2014-1027 PMID: 24762141 10.1210\/en.2014\u2013\u20091027.","journal-title":"Endocrinology"},{"key":"592_CR19","doi-asserted-by":"publisher","unstructured":"Sergeeva A, Davydova K, Perenkov A, Vedunova M. Mechanisms of human DNA methylation, alteration of methylation patterns in physiological processes and oncology. Gene. 2023;875. https:\/\/doi.org\/10.1016\/j.cellsig.2017.01.017 PMID: WOS:001011456200001. ARTN 147487.","DOI":"10.1016\/j.cellsig.2017.01.017"},{"key":"592_CR20","doi-asserted-by":"publisher","unstructured":"Zhu X, Xue CY, Kang XF, Jia XM, Wang L, Younis MH, Liu DH, Huo N, Han YC, Chen Z et al. DNMT3B-mediated FAM111B methylation promotes papillary thyroid tumor glycolysis, growth and metastasis. Int J Biol Sci. 2022;18(11):4372-87. https:\/\/doi.org\/10.7150\/ijbs.72397. PMID: WOS:000832879400008.","DOI":"10.7150\/ijbs.72397"},{"key":"592_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cellsig.2017.01.017","volume":"32","author":"Z Quan","year":"2017","unstructured":"Quan Z, He YF, Luo CL, Xia Y, Zhao Y, Liu NJ, Wu XH. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing HepaCAM via the STAT3-dependent up-regulation of DNMTI or DNMT3B. Cell Signal. 2017;32:48\u201358. https:\/\/doi.org\/10.1016\/j.cellsig.2017.01.017. PMID: WOS:000395953400005.","journal-title":"Cell Signal"},{"key":"592_CR22","doi-asserted-by":"publisher","unstructured":"Ren GL, Li HY, Hong D, Hu FY, Jin RJ, Wu S, Sun WH, Jin HL, Zhao LL, Zhang XD et al. LINC00955 suppresses colorectal cancer growth by acting as a molecular scaffold of TRIM25 and Sp1 to inhibit DNMT3B-mediated methylation of the PHIP promoter. BMC Cancer. 2023;23(1). https:\/\/doi.org\/10.1186\/s12885-023-11403-2. PMID: WOS:001075729700003 ARTN 898.","DOI":"10.1186\/s12885-023-11403-2"},{"issue":"1","key":"592_CR23","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1038\/s41467-022-34011-3","volume":"13","author":"M Zethoven","year":"2022","unstructured":"Zethoven M, Martelotto L, Pattison A, Bowen B, Balachander S, Flynn A, Rossello FJ, Hogg A, Miller JA, Frysak Z, et al. Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment. Nat Commun. 2022;13(1):6262. https:\/\/doi.org\/10.1038\/s41467-022-34011-3. PMID: 36271074.","journal-title":"Nat Commun"},{"key":"592_CR24","doi-asserted-by":"publisher","unstructured":"Wang R, Zhang G, Zhu X, Xu Y, Cao N, Li Z, Han C, Qin M, Shen Y, Dong J, et al. Prognostic implications of LRP1B and its relationship with the Tumor-Infiltrating immune cells in gastric Cancer. Cancers (Basel). 2023;15(24). https:\/\/doi.org\/10.3390\/cancers15245759. PMID: 38136305.","DOI":"10.3390\/cancers15245759"},{"issue":"1","key":"592_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41598-023-50680-6","volume":"14","author":"Y Song","year":"2024","unstructured":"Song Y, Kim N, Heo J, Shum D, Heo T, Seo HR. Inhibition of DNMT3B expression in activated hepatic stellate cells overcomes chemoresistance in the tumor microenvironment of hepatocellular carcinoma. Sci Rep. 2024;14(1):115. https:\/\/doi.org\/10.1038\/s41598-023-50680-6. PMID: 38168140.","journal-title":"Sci Rep"},{"key":"592_CR26","doi-asserted-by":"publisher","first-page":"111594","DOI":"10.1016\/j.mce.2022.111594","volume":"547","author":"S Martinelli","year":"2022","unstructured":"Martinelli S, Riverso M, Mello T, Amore F, Parri M, Simeone I, Mannelli M, Maggi M, Rapizzi E. SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism. Mol Cell Endocrinol. 2022;547:111594. https:\/\/doi.org\/10.1016\/j.mce.2022.111594. PMID: 35149119.","journal-title":"Mol Cell Endocrinol"},{"key":"592_CR27","doi-asserted-by":"publisher","first-page":"1137456","DOI":"10.3389\/fendo.2023.1137456","volume":"14","author":"S Martinelli","year":"2023","unstructured":"Martinelli S, Amore F, Canu L, Maggi M, Rapizzi E. Tumour microenvironment in pheochromocytoma and paraganglioma. Front Endocrinol (Lausanne). 2023;14:1137456. https:\/\/doi.org\/10.3389\/fendo.2023.1137456. PMID: 37033265.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"592_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/cas.12157","volume":"104","author":"SB Ni","year":"2013","unstructured":"Ni SB, Hu JR, Duan YS, Shi SL, Li R, Wu HJ, Qu YP, Li Y. Down expression of promotes cell migration via RhoA\/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer. Cancer Sci. 2013;104(7):817\u201325. https:\/\/doi.org\/10.1111\/cas.12157. PMID: WOS:000325680000006.","journal-title":"Cancer Sci"},{"issue":"11","key":"592_CR29","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1158\/0008-5472.CAN-04-0172","volume":"64","author":"I Sonoda","year":"2004","unstructured":"Sonoda I, Imoto I, Inoue J, Shibata T, Shimada Y, Chin K, Imamura M, Amagasa T, Gray JW, Hirohashi S, et al. Frequent Silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res. 2004;64(11):3741\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0172. PMID: 15172977.","journal-title":"Cancer Res"},{"issue":"11","key":"592_CR30","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/onc.2010.512","volume":"30","author":"H Prazeres","year":"2011","unstructured":"Prazeres H, Torres J, Rodrigues F, Pinto M, Pastoriza MC, Gomes D, Cameselle-Teijeiro J, Vidal A, Martins TC, Sobrinho-Simoes M, et al. Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells. Oncogene. 2011;30(11):1302\u201317. https:\/\/doi.org\/10.1038\/onc.2010.512. PMID: 21057533.","journal-title":"Oncogene"},{"issue":"4","key":"592_CR31","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1124\/pharmrev.122.000810","volume":"75","author":"W Sadee","year":"2023","unstructured":"Sadee W, Wang D, Hartmann K, Toland AE. Pharmacogenomics: driving personalized medicine. Pharmacol Rev. 2023;75(4):789\u2013814. https:\/\/doi.org\/10.1124\/pharmrev.122.000810. PMID: 36927888.","journal-title":"Pharmacol Rev"},{"key":"592_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jconrel.2014.11.011","volume":"205","author":"SY Li","year":"2015","unstructured":"Li SY, Sun R, Wang HX, Shen S, Liu Y, Du XJ, Zhu YH, Jun W. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells. J Control Release. 2015;205:7\u201314. https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.011. PMID: 25445694.","journal-title":"J Control Release"}],"container-title":["Epigenetics & Chromatin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-025-00592-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13072-025-00592-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-025-00592-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T03:23:55Z","timestamp":1746761035000},"score":1,"resource":{"primary":{"URL":"https:\/\/epigeneticsandchromatin.biomedcentral.com\/articles\/10.1186\/s13072-025-00592-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["592"],"URL":"https:\/\/doi.org\/10.1186\/s13072-025-00592-8","relation":{},"ISSN":["1756-8935"],"issn-type":[{"value":"1756-8935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The collection of tissue samples obtained approval from the Ethics Committee of People\u2019s Hospital of Xinjiang Uygur Autonomous Region (No. KY2023060156).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}